CervoMed Inc. - Common Stock CRVO 深 滬
已收盤 09-19 16:00:00 美东时间
17.47
+1.670
+10.57%
華盛通- 最 高19.50
- 今 開16.13
- 成交量 21.68万股
- 最 低 16.13
- 昨 收 15.80
- 總市值 1.08亿
- 52周最高 26.3789
- 市盈率 靜 --
- 換手率 3.51%
- 52周最低 4.28
- 委 比 71.99%
- 總股本 617.05万
- 歷史最高 17437.50
- 量 比 2.07
- 振 幅 21.33%
- 歷史最低 4.14
- 每 手 1
- 風險率 5.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多罗氏(RHHBY.US)双特异性抗体Vabysmo获欧盟批准
7月31日，罗氏(RHHBY.US)宣布，欧盟委员会(EC)已批准双特异性抗体Vabysmo(faricimab)用于治疗由于视网膜静脉阻塞(RVO)引起的黄斑水肿导致的视力损害。
07-31 08:34
Canaccord Genuity Maintains Buy on CervoMed, Maintains $65 Price Target
Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed (NASDAQ:CRVO) with a Buy and maintains $65 price target.
07-25 21:09
CervoMed Discusses Neflamapimod in Virtual Investor Event
The latest announcement is out from CervoMed (CRVO). CervoMed Inc. is set to ho...
07-23 19:58
CervoMed to Participate in the Emerging Growth Conference
BOSTON, July 17, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clini...
07-17 20:00
CervoMed announces addition to Russell 2000, Russell 3000 Indexes
CervoMed (NASDAQ:CRVO) has announced its expected addition to the Russell 2000® and 3000® Indexes, effective when the U.S. equity markets open on Monday, July 1, 2024. “We look forward to the further ...
06-24 20:36
SCPX, XTIA and CRVO among mid-day movers
Gainers: MultiMetaVerse Holdings Limited (MMV) +184%. GT Biopharma (GTBP) +164%. NKGen Biotech (NKGN) +54%. Bruush Oral Care (BRSH) +47%. Faraday Future Intelligent Electric (FFIE) +45%. Scorpius Hold...
05-21 01:12
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-16 18:50
CervoMed Q1 EPS $(0.41) Misses $(0.39) Estimate, Sales $2.35M Beat $1.35M Estimate
CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by 5.13 percent. This is a 78.97 percent increase over losses of $(1.95) per share from the
05-15 20:14
CervoMed Updates Stakeholders on Clinical and Financial Status
CervoMed (CRVO) has provided an announcement. CervoMed Inc. has made key detail...
04-23 20:13
加拿大投资银行集团：维持CervoMed(CRVO.US)评级，由买入调整至买入评级, 目标价由50.00美元调整至65.00美元。
加拿大投资银行集团：维持CervoMed(CRVO.US)评级，由买入调整至买入评级, 目标价由50.00美元调整至65.00美元。
04-08 19:40
